Translation and cross-cultural validation of the non-invasive prenatal testing questionnaire in Arabic

References

1. ↵
   1. Carlson LM,
   2. Vora NL

   (2017) Prenatal diagnosis:Screening and diagnostic tools. Obstet Gynecol Clin North Am 44:245–256.
2. ↵
   1. Nussbaum RL,
   2. McInnes RR,
   3. Willard HF

   (2015) Thompson &Thompson genetics in medicine e-book (Elsevier Health Sciences, Philadelphia (PA)), 8th ed.
3. ↵
   1. Goetzinger KR,
   2. Shanks AL,
   3. Odibo AO,
   4. Macones GA,
   5. Cahill AG

   (2017) Advanced maternal age and the risk of major congenital anomalies. Am J Perinatol 34:217–222.
4. ↵
   1. Temming LA,
   2. Macones GA

   (2016) What is prenatal screening and why to do it? Semin Perinatol 40:3–11.
5. ↵
   1. de Jong A,
   2. Maya I,
   3. van Lith JM

   (2015) Prenatal screening:current practice, new developments, ethical challenges. Bioethics 29:1–8.
6. ↵
   1. Kagan KO,
   2. Sonek J,
   3. Wagner P,
   4. Hoopmann M

   (2017) Principles of first trimester screening in the age of non-invasive prenatal diagnosis:screening for chromosomal abnormalities. Arch Gynecol Obstet 296:645–651.
7. ↵
   1. Wu G,
   2. Li R,
   3. Tong C,
   4. He M,
   5. Qi Z,
   6. Chen H,
   7. et al.

   (2019) Non-invasive prenatal testing reveals copy number variations related to pregnancy complications. Mol Cytogenet 12:38.
8. ↵
   1. Burnum-Johnson KE,
   2. Baker ES,
   3. Metz TO

   (2017) Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging. Placenta 60(Suppl 1 (Suppl 1)):S67–S72.
9. ↵
   1. Dar P,
   2. Shani H,
   3. Evans MI

   (2016) Cell-free DNA:Comparison of Technologies. Clin Lab Med 36:199–211.
10. ↵
    1. Allyse M,
    2. Minear MA,
    3. Berson E,
    4. Sridhar S,
    5. Rote M,
    6. Hung A,
    7. Chandrasekharan S

    (2015) Non-invasive prenatal testing:a review of international implementation and challenges. Int J Womens Health 7:113–126.
11. ↵
    1. Filoche S,
    2. Lawton B,
    3. Beard A,
    4. Dowell A,
    5. Stone P

    (2017) New screen on the block:non-invasive prenatal testing for fetal chromosomal abnormalities. J Prim Health Care 9:248–253.
12. ↵
    1. Gil MM,
    2. Accurti V,
    3. Santacruz B,
    4. Plana MN,
    5. Nicolaides KH

    (2017) Analysis of cell-free DNA in maternal blood in screening for aneuploidies:updated meta-analysis. Ultrasound Obstet Gynecol 50:302–314.
13. ↵
    1. Sahlin E,
    2. Nordenskjöld M,
    3. Gustavsson P,
    4. Wincent J,
    5. Georgsson S,
    6. Iwarsson E

    (2016) Positive attitudes towards non-invasive prenatal testing (NIPT) in a Swedish cohort of 1,003 pregnant women. PloS One 11:e0156088.
14. ↵
    World Health Organization. Process of translation and adaptation of instruments, [cited 2009]. Available from URL: http://www.who.int/substance_abuse/research_tools/translation/en/.
15. ↵
    1. Zheng Y,
    2. Wan S,
    3. Dang Y,
    4. Song T,
    5. Chen B,
    6. Zhang J

    (2019) Non-invasive prenatal testing for detection of trisomy 13, 18, 21 and sex chromosome aneuploidies in →cases. Ginekol Pol 90:270–273.
16. ↵
    1. Al-Zalabani AH

    (2019) Adaptation and validation of the Arabic version of self-efficacy scale for mammography. Saudi Med J 40:707–713.